The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurochemistry

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1471-4159.1999.721681.XPMID 10098877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.

  1998cited by this paper
• Amyloid-specific Heparan Sulfate from Human Liver and Spleen*

  1997cited by this paper
• Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

  1997cited by this paper
• Aβ(1–40) Prevents Heparanase-catalyzed Degradation of Heparan Sulfate Glycosaminoglycans and Proteoglycans in Vitro

  1997cited by this paper
• Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.

  1997cited by this paper
• Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability

  1997cited by this paper
• Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.

  1997cited by this paper
• Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

  1997cited by this paper
• Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits.

  1996cited by this paper
• Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits

  1996cited by this paper
• First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.

  1996cited by this paper
• Identification and Immunolocalization of a New Class of Proteoglycan (Keratan Sulfate) to the Neuritic Plaques of Alzheimer's Disease

  1996cited by this paper
• Transforming growth factor beta 1 increases the synthesis and shedding of the melanoma-specific proteoglycan in human melanoma cells.

  1996cited by this paper
• Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.

  1996cited by this paper
• Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

  1995cited by this paper
• Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.

  1995cited by this paper
• Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.

  1995cited by this paper
• Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.

  1995cited by this paper
• Activation of proteoglycan synthesis in injured liver : a brief review of molecular and cellular aspects

  1994cited by this paper
• An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain

  1994cited by this paper
• An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.

  1994cited by this paper
• Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.

  1994cited by this paper
• Activation of proteoglycan synthesis in injured liver--a brief review of molecular and cellular aspects.

  1994cited by this paper
• pH‐Dependent Binding of Synthetic β‐Amyloid Peptides to Glycosaminoglycans

  1993cited by this paper
• alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.

  1993cited by this paper
• Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease.

  1993cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.

  1993cited by this paper
• Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro.

  1993cited by this paper
• pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans.

  1993cited by this paper
• Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.

  1993cited by this paper
• Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.

  1993cited by this paper
• α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease

  1993cited by this paper
• Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions

  1992cited by this paper
• Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.

  1992cited by this paper
• Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease.

  1992cited by this paper
• Kinetic analysis of amyloid fibril polymerization in vitro.

  1991cited by this paper
• Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells.

  1991cited by this paper
• High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.

  1991cited by this paper
• Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.

  1990cited by this paper
• Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.

  1990cited by this paper
• Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan.

  1990cited by this paper
• Transforming growth factor beta alters the expression of heparan sulfate proteoglycan in human colon carcinoma cells.

  1990cited by this paper
• Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease.

  1990cited by this paper
• A 66KD HEAT-STABLE NEURONAL PROTEIN REACTS WITH AN ANTISERUM TO THE BETA-AMYLOID PRECURSOR PROTEIN: 155

  1989cited by this paper
• Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.

  1989cited by this paper
• A CHARACTERISTIC BINDING AFFINITY BETWEEN HEPARAN SULFATE PROTEOGLYCANS AND THE A4 AMYLOID PROTEIN OF ALZHEIMERʼS DISEASE: 154

  1989cited by this paper
• The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.

  1988cited by this paper
• Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans.

  1988cited by this paper
• Characterization of heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells in culture.

  1983cited by this paper
• Periodate oxidation and alkaline degradation of heparin-related glycans

  1980cited by this paper
• Distribution of sulphate and iduronic acid residues in heparin and heparan sulphate.

  1974cited by this paper
• ON THE BINDING OF CONGO RED BY AMYLOID

  1962cited by this paper

• Agrin at the Crossroads of Aging: A Pleiotropic Regulator in Age-Related Diseases.

  2026cites this paper
• Chiroptical switching and strong circularly polarized luminescence in peptide supramolecular assemblies

  2025cites this paper
• Multi-omic analysis of meningeal cerebral amyloid angiopathy reveals enrichment of unsubstituted glucosamine and extracellular proteins

  2025cites this paper
• Kinetic Mechanism of Heparin-Induced Fibrillation of α-Synuclein.

  2025cites this paper
• The glycosaminoglycan chains of perlecan regulate the perivascular fluid transport

  2025cites this paper
• Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients

  2024cites this paper
• NMR studies of amyloid interactions.

  2024cites this paper
• Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues

  2024cites this paper
• A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils

  2024cites this paper
• Elucidating the Mechanism of Recognition and Binding of Heparin to Amyloid Fibrils of Serum Amyloid A.

  2024cites this paper
• Unravelling heparin's enhancement of amyloid aggregation in a model peptide system.

  2024cites this paper
• Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection

  2023cites this paper
• Heparan Sulfate in Alzheimer's Disease: Aberrant expression and functions in molecular pathways related to amyloid-β metabolism.

  2023cites this paper
• Submucosal injection of the RNA oligonucleotide GUT-1 in active ulcerative colitis patients: A randomized, double-blind, placebo-controlled phase 2a induction trial.

  2023cites this paper
• Synthetic Sulfated Polymers Control Amyloid Aggregation of Ovine Prion Protein and Decrease Its Toxicity

  2022cites this paper
• Isolation and Characterization of Heparan Sulfate Containing Amyloid Precursor Protein Degradation Products.

  2022cites this paper
• Design and Synthesis of 6‐O‐Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation

  2022cites this paper
• Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide

  2022cites this paper
• Heparin-Assisted Amyloidogenesis Uncovered through Molecular Dynamics Simulations

  2022cites this paper
• Basal lamina changes in neurodegenerative disorders

  2021cites this paper
• Role of the Extracellular Matrix in Alzheimer’s Disease

  2021cites this paper
• In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss

  2021cites this paper
• Disease-specific glycosaminoglycan patterns in the extracellular matrix of human lung and brain.

  2021cites this paper
• The Effects of Different Glycosaminoglycans on the Structure and Aggregation of the Amyloid-β (16-22) Peptide.

  2021cites this paper
• Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates

  2021cites this paper
• To target Tau pathologies, we must embrace and reconstruct their complexities.

  2021cites this paper
• The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago

  2021cites this paper
• Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease

  2021cites this paper
• Glycosaminoglycans in Neurodegenerative Diseases.

  2021cites this paper
• Raman spectroscopy with 2D perturbation correlation moving windows for the characterisation of heparin-amyloid interactions.

  2020cites this paper
• Circular dichroism spectroscopy identifies the β-adrenoceptor agonist salbutamol as a direct inhibitor of tau filament formation in vitro.

  2020cites this paper
• Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA

  2020cites this paper
• Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.

  2020cites this paper
• The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives

  2020cites this paper
• Perineuronal nets in brain physiology and disease.

  2019cites this paper
• The Amazon rain forest plant Uncaria tomentosa (cat’s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles

  2019cites this paper
• Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression

  2019cites this paper
• The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity.

  2019cites this paper
• Electrostatic Complementarity drives Amyloid/Nucleic Acid Co-assembly.

  2019cites this paper
• Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer's disease

  2019cites this paper
• Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

  2019cites this paper
• Molecular insights into amyloid toxicity using model lipid membranes

  2019cites this paper
• IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies.

  2018cites this paper
• Cell surface proteoglycan-mediated uptake and accumulation of the Alzheimer's disease peptide Aβ(1-42).

  2018cites this paper
• Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases

  2018cites this paper
• Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin

  2018cites this paper
• Heparin Modulates the Kinetics of Zinc-Induced Aggregation of Amyloid-β Peptides

  2018cites this paper
• Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish

  2018cites this paper
• Proteoglycans in brain development and pathogenesis

  2018cites this paper
• Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation

  2017influential citation
• Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils.

  2017cites this paper
• Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type

  2017cites this paper
• Self-assembling peptide hydrogels for articular cartilage repair

  2017cites this paper
• New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease.

  2017cites this paper
• α-synuclein aggregation and its modulation.

  2017cites this paper
• Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design

  2017cites this paper
• Sulfated glycosaminoglycans in protein aggregation diseases

  2017cites this paper
• Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils

  2017cites this paper
• Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders.

  2017cites this paper
• Chondroitin sulfates and their binding molecules in the central nervous system

  2017cites this paper
• Enzymatic remodeling of heparan sulfate: a therapeutic strategy for systemic and localized amyloidoses?

  2016cites this paper
• Étude de la régulation d’expression et des activités des héparanes 3-O-sulfotransférases 2, 3A et 3B dans les macrophages

  2016cites this paper
• Reduced molecular size and altered disaccharide composition of cerebral chondroitin sulfate upon Alzheimer’s pathogenesis in mice

  2016cites this paper
• Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A

  2016cites this paper
• Development of glycosaminoglycan mimetics using glycopolymers

  2016cites this paper
• How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin*

  2016cites this paper
• The effects of chondroitin sulfate and serum albumin on the fibrillation of human islet amyloid polypeptide at phospholipid membranes.

  2016cites this paper
• The Structure-Activity Relationship of Glycosaminoglycans and Their Analogues with β-Amyloid Peptide.

  2016cites this paper
• Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease

  2016cites this paper
• Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β Fibrils.

  2016cites this paper
• Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease

  2016cites this paper
• Brittlestars Galactosaminoglycans and Tools to Study their Structure

  2016cites this paper
• ADAMTS4, 5, 9, and 15 expressions in the autopsied brain of patients with Alzheimer’s disease: a preliminary immunohistochemistry study -

  2016cites this paper
• Cellular Interaction and Cytotoxicity of the Iowa Mutation of Apolipoprotein A-I (ApoA-IIowa) Amyloid Mediated by Sulfate Moieties of Heparan Sulfate*

  2015cites this paper
• "GAG-ing with the neuron": The role of glycosaminoglycan patterning in the central nervous system.

  2015cites this paper
• Positively Charged Chitosan and N-Trimethyl Chitosan Inhibit Aβ40 Fibrillogenesis.

  2015cites this paper
• The role of syndecan-2 in amyloid plaque formation

  2015cites this paper
• Contrôler la plasticité du cortex cérébral adulte à travers l'action non-autonome de l'homéoprotéine Otx2

  2015cites this paper
• Role of Syndecans in Lipid Metabolism and Human Diseases.

  2015cites this paper
• Selection of RNA aptamers and their recognition of amyloid assemblies

  2015cites this paper
• The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity

  2015influential citation
• Amylin Structure, Aggregation and Pancreatic β Cell Toxicity

  2015cites this paper
• Heparin nanoparticles for β amyloid binding and mitigation of β amyloid associated cytotoxicity.

  2015cites this paper
• Islet amyloid polypeptide (IAPP) in Type 2 diabetes and Alzheimer disease

  2015cites this paper
• Glycosaminoglycans and Fibrillar Polymorphism

  2014cites this paper
• Mechanisms of amyloid fibril formation

  2014cites this paper
• A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease

  2014cites this paper
• Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease.

  2014cites this paper
• Biofysikaliska studier av amyloida proteinfibrillers kompaktering

  2014cites this paper
• Review: Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair

  2014cites this paper
• The protease activity of transthyretin reverses the effect of pH on the amyloid-β protein/heparan sulfate proteoglycan interaction: a biochromatographic study.

  2014cites this paper
• Mécanisme d'association de deux protéines amyloïdogènes de l'héparane sulfate protéoglycane. Rôle du pH et de l'activité protéasique de la transthyrétine

  2014cites this paper
• Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.

  2014cites this paper
• Reduced amyloid burden in AβPP/heparanase double-transgenic mice

  2014influential citation
• Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic Mice*

  2014influential citation
• Hormone amyloids in sickness and in health

  2013cites this paper
• Genome-wide scan of job-related exhaustion with three replication studies implicate a susceptibility variant at the UST gene locus.

  2013cites this paper
• Proteoglycans in the central nervous system: Role in development, neural repair, and Alzheimer's disease

  2013cites this paper
• Sugar glues for broken neurons

  2013cites this paper
• Surface-bound basement membrane components accelerate amyloid-β peptide nucleation in air-free wells: an in vitro model of cerebral amyloid angiopathy.

  2013cites this paper